ChemoMetec A/S

Equities

CHEMM

DK0060055861

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:36 2024-05-02 am EDT			5-day change	1st Jan Change
290 ^DKK	-1.63%		-0.41%	-25.26%

Apr. 12	Chemometec A/S Reports Revenue for the Third Quarter and First Nine Months of 2023 -2024	CI
Apr. 12	ChemoMetec A/S Provides Earnings Guidance for the Year 2023/24	CI

ChemoMetec A/S Maintains Earnings Guidance for the Year 2024

February 05, 2024 at 02:00 pm EST

ChemoMetec A/S maintained earnings guidance for the year 2024. The company maintain full-year guidance for 2023/24 of revenue in the range of DKK 400 million - DKK 435 million and EBITDA in the range of DKK 200 million - DKK 220 million.

Latest news about ChemoMetec A/S

Chemometec A/S Reports Revenue for the Third Quarter and First Nine Months of 2023 -2024	Apr. 12	CI
ChemoMetec A/S Provides Earnings Guidance for the Year 2023/24	Apr. 12	CI
ChemoMetec Appoints COO as New CEO	Mar. 13	MT
ChemoMetec A/S Announces CEO Changes	Mar. 13	CI
Transcript : ChemoMetec A/S, H1 2024 Earnings Call, Feb 06, 2024	Feb. 06
ChemoMetec A/S Maintains Earnings Guidance for the Year 2024	Feb. 05	CI
ChemoMetec A/S Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 05	CI
ChemoMetec A/S Announces Executive Changes	Dec. 20	CI
Transcript : ChemoMetec A/S, 2023 Earnings Call, Sep 14, 2023	23-09-14
ChemoMetec A/S Reports Earnings Results for the Full Year Ended June 30, 2023	23-09-13	CI
Chemometec A/S Proposes Dividend for the 2022/23 Financial Year	23-09-13	CI
Chemometec A/S Provides Earnings Guidance for the 2023-2024 Financial Year	23-09-13	CI
ChemoMetec A/S Affirms Earnings Guidance for the Fiscal Year 2022/2023	23-05-08	CI
ChemoMetec A/S Appoints Rasmus Kofoed as CEO, Effective No Later Than 1 August 2023	23-04-17	CI
ChemoMetec A/S Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-08	CI
ChemoMetec A/S Updates Earnings Guidance for the Fiscal Year 2022/2023	23-02-08	CI
Chemometec A/S Announces Resignation of Steen Søndergaard as CEO	22-12-14	CI
ChemoMetec A/S Provides Earnings Guidance for the Financial Year 2022-23	22-11-08	CI
ChemoMetec A/S Reports Earnings Results for the Full Year Ended June 30, 2022	22-09-15	CI
ChemoMetec A/S Reports Earnings Results for the Full Year Ended June 30, 2022	22-09-15	CI
ChemoMetec A/S Provides Revenue Guidance for the Fiscal Year 2023	22-09-15	CI
ChemoMetec A/S Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-08	CI
Chemometec A/S Reaffirms Earnings Guidance for the Financial Year 2021-2022	21-11-04	CI
ChemoMetec Appoints Bent Faurskov as New CFO from 1 October 2021	21-06-30	CI
Chemometec A/S Announces Unaudited Consolidated Earnings Results for the First Half Ended December 31, 2020	21-02-05	CI

Chart ChemoMetec A/S

Duration

Period

More charts

Company Profile

Chemometec A/S is a Denmark-based company engaged in the development, manufacture and sale of analytical instruments used for quantitative analysis of cells in liquids. The Companyâs activities are divided into three business areas: Instruments, which offers a range of NucleoCounter analytical instruments for counting mammalian, animal, yeast and sperm cells, as well as somatic cells in milk, among others; Consumables, which distributes disposable cassettes, solutions, reagents and slides; and Other, which is responsible for the partnership development in a number of research projects, among others. The Companyâs analytical products are based on a technology, which combines fluorescence microscopy with digital imagery. Its customer portfolio comprises entities active primarily within pharmaceutical, food processing and agriculture industries. Furthermore, the Company is a parent of ChemoMetec USA Inc.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-07 - Q3 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for ChemoMetec A/S

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

290 DKK

Average target price

462.5 DKK

Spread / Average Target

+59.48%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
CHEMOMETEC A/S	-25.26%	735M
SHOCKWAVE MEDICAL, INC.	+73.17%	12.37B
PENUMBRA, INC.	-18.08%	7.96B
MASIMO CORPORATION	+16.24%	7.09B
GETINGE AB	+3.39%	5.83B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+11.77%	5.35B
APT MEDICAL INC.	+29.65%	4.63B
ASAHI INTECC CO., LTD.	-17.74%	4B
INARI MEDICAL, INC.	-35.34%	2.41B
SKAN GROUP AG	+2.10%	2B

Medical Equipment